Retractable Technologies Reports 30.8% Decline in Q2 2026 Net Sales

Retractable Technologies, Inc. reported a significant decline in financial performance for the second quarter of 2026, with net sales of $7.2 million, down 30.8% from $10.4 million in the same period last year. For the first half of 2026, total revenue was $14.4 million, a decrease of 23.3% compared to $18.7 million in the first half of 2025. The company experienced a net income of $2.8 million for the second quarter, a notable improvement from a net loss of $87,471 in the same quarter of 2025. However, the overall net loss for the first half of 2026 was $1.4 million, compared to a loss of $10.6 million in the prior year.

The company’s operational metrics reflected a decrease in unit sales, particularly in its EasyPoint® product line, which contributed to the overall decline in revenue. Domestic sales accounted for 81.6% of total revenues in the second quarter of 2026, with a 35.1% drop in domestic unit sales. International revenues also fell by 32.2%, primarily due to reduced EasyPoint® needle sales. The company noted that the decrease in sales was influenced by fluctuating customer purchasing patterns and ongoing tariff impacts on imported goods.

In terms of strategic developments, Retractable Technologies has been adapting its manufacturing capabilities to increase domestic production, particularly in response to tariffs imposed on imported syringes and needles. The company reported that 57.6% of its products were sourced from Chinese manufacturers in the first half of 2026, a figure that has raised concerns about supply chain stability due to ongoing tariff issues. The company is also working to enhance its international sales following recent certification under the European Union Medical Device Regulation, which is expected to facilitate increased sales of its VanishPoint syringes and EasyPoint needles in the EU market.

The company’s balance sheet as of June 30, 2026, showed total assets of $141.7 million, a slight decrease from $142.6 million at the end of 2025. Current liabilities increased significantly to $13.4 million from $9.6 million, primarily due to higher accounts payable and accrued liabilities. The company’s cash and cash equivalents rose to $2.6 million, up from $2.6 million at the end of 2025, reflecting a net cash increase despite operational losses. The company also reported a significant unrealized gain of $13,000 on its investment portfolio, which totaled $37.2 million.

Looking ahead, Retractable Technologies anticipates continued challenges due to tariff impacts and fluctuating demand for its products. The company plans to mitigate these challenges through strategic sourcing and increased domestic production. Additionally, the recent workforce reduction of approximately 16% is expected to yield annual savings of about $2.2 million, which may help improve financial stability in the coming periods. The company remains focused on enhancing its operational efficiency and expanding its market presence, particularly in international markets.